Marike Gabrielson

6.3k total citations
32 papers, 573 citations indexed

About

Marike Gabrielson is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marike Gabrielson has authored 32 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Marike Gabrielson's work include Breast Cancer Treatment Studies (15 papers), Digital Radiography and Breast Imaging (15 papers) and Cancer Risks and Factors (7 papers). Marike Gabrielson is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Digital Radiography and Breast Imaging (15 papers) and Cancer Risks and Factors (7 papers). Marike Gabrielson collaborates with scholars based in Sweden, Denmark and United Kingdom. Marike Gabrielson's co-authors include Per Hall, Kamila Czene, Mikael Eriksson, Shadi Azam, Mattias Hammarström, Signe Borgquist, Arvid Sjölander, Maria C. Shoshan, Karin Leifland and Joseph W. Carlson and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Marike Gabrielson

32 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marike Gabrielson Sweden 14 251 195 169 153 123 32 573
Ninah Achacoso United States 19 456 1.8× 331 1.7× 158 0.9× 245 1.6× 64 0.5× 49 808
Syed A. Ahmed United States 10 304 1.2× 149 0.8× 107 0.6× 224 1.5× 58 0.5× 16 644
CM Vachon United States 5 299 1.2× 160 0.8× 208 1.2× 38 0.2× 94 0.8× 9 503
Louise Eriksson Sweden 12 322 1.3× 264 1.4× 290 1.7× 60 0.4× 65 0.5× 18 590
Janne Malina Sweden 14 267 1.1× 218 1.1× 430 2.5× 177 1.2× 126 1.0× 19 895
José E. Alés‐Martínez Spain 9 469 1.9× 343 1.8× 157 0.9× 155 1.0× 479 3.9× 20 924
Galina Lurie United States 18 341 1.4× 122 0.6× 259 1.5× 79 0.5× 195 1.6× 23 827
Min Kyoon Kim South Korea 13 218 0.9× 194 1.0× 59 0.3× 114 0.7× 44 0.4× 36 485
Sònia Servitja Spain 21 734 2.9× 242 1.2× 121 0.7× 321 2.1× 224 1.8× 54 1.1k
Melanie R. Palomares United States 14 154 0.6× 195 1.0× 152 0.9× 197 1.3× 226 1.8× 35 683

Countries citing papers authored by Marike Gabrielson

Since Specialization
Citations

This map shows the geographic impact of Marike Gabrielson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marike Gabrielson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marike Gabrielson more than expected).

Fields of papers citing papers by Marike Gabrielson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marike Gabrielson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marike Gabrielson. The network helps show where Marike Gabrielson may publish in the future.

Co-authorship network of co-authors of Marike Gabrielson

This figure shows the co-authorship network connecting the top 25 collaborators of Marike Gabrielson. A scholar is included among the top collaborators of Marike Gabrielson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marike Gabrielson. Marike Gabrielson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göransson, Sara, Pablo Hernández-Varas, Mattias Hammarström, et al.. (2024). Low-dose tamoxifen treatment reduces collagen organisation indicative of tissue stiffness in the normal breast: results from the KARISMA randomised controlled trial. Breast Cancer Research. 26(1). 1 indexed citations
2.
Gabrielson, Marike, Mattias Hammarström, Kristina Lång, et al.. (2024). Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change. International Journal of Cancer. 155(2). 339–351. 4 indexed citations
3.
Gabrielson, Marike, Mattias Hammarström, L. Magnus Bäcklund, et al.. (2023). Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six‐arm placebo‐controlled trial in healthy women. International Journal of Cancer. 152(11). 2362–2372. 6 indexed citations
4.
Mälarstig, Anders, Felix Graßmann, Marios Dimitriou, et al.. (2023). Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nature Communications. 14(1). 7680–7680. 19 indexed citations
5.
Hammarström, Mattias, Marike Gabrielson, Alessio Crippa, et al.. (2023). Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women. British Journal of Cancer. 129(1). 61–71. 16 indexed citations
6.
Thomas, Cecilia Engel, Yan Chen, Mathias Uhlén, et al.. (2022). Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer. Translational Oncology. 17. 101339–101339. 5 indexed citations
7.
Azam, Shadi, Mikael Eriksson, Arvid Sjölander, et al.. (2021). Mammographic microcalcifications and risk of breast cancer. British Journal of Cancer. 125(5). 759–765. 43 indexed citations
8.
He, Wei, Mikael Eriksson, Erik Eliasson, et al.. (2021). CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial. Annals of Oncology. 32(10). 1286–1293. 23 indexed citations
9.
Gabrielson, Marike, Shadi Azam, Mikael Eriksson, et al.. (2020). Hormonal determinants of mammographic density and density change. Breast Cancer Research. 22(1). 95–95. 24 indexed citations
10.
Azam, Shadi, Mikael Eriksson, Arvid Sjölander, et al.. (2019). Mammographic Density Change and Risk of Breast Cancer. JNCI Journal of the National Cancer Institute. 112(4). 391–399. 34 indexed citations
11.
Azam, Shadi, Mikael Eriksson, Arvid Sjölander, et al.. (2019). Mammographic density change and risk of breast cancer. Annals of Oncology. 30. iii4–iii5. 5 indexed citations
12.
Gabrielson, Marike, et al.. (2018). Association of reproductive history with breast tissue characteristics and receptor status in the normal breast. Breast Cancer Research and Treatment. 170(3). 487–497. 12 indexed citations
13.
Eklund, Martin, Mun‐Gwan Hong, Claudia Fredolini, et al.. (2018). Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density. Breast Cancer Research. 20(1). 14–14. 8 indexed citations
14.
Gabrielson, Marike, Emina Vorkapić, Maggie Folkesson, et al.. (2016). Altered PPARγ Coactivator-1 Alpha Expression in Abdominal Aortic Aneurysm: Possible Effects on Mitochondrial Biogenesis. Journal of Vascular Research. 53(1-2). 17–26. 13 indexed citations
15.
Gabrielson, Marike, Flaminia Chiesa, Janna Paulsson, et al.. (2016). Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues. Breast Cancer Research and Treatment. 158(2). 253–261. 16 indexed citations
16.
Gabrielson, Marike, et al.. (2015). Mitochondrial regulation of cell cycle progression through SLC25A43. Biochemical and Biophysical Research Communications. 469(4). 1090–1096. 9 indexed citations
17.
Gabrielson, Marike, et al.. (2014). Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma. PLoS ONE. 9(9). e107109–e107109. 42 indexed citations
18.
Gabrielson, Marike & Elisabet Tina. (2013). The mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell lines. Oncology Reports. 29(4). 1268–1274. 8 indexed citations
19.
20.
Plaisant, Magali, Sophie Giorgetti‐Peraldi, Marike Gabrielson, et al.. (2011). Inhibition of Hedgehog Signaling Decreases Proliferation and Clonogenicity of Human Mesenchymal Stem Cells. PLoS ONE. 6(2). e16798–e16798. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ninah Achacoso Breakdown of academic impact, for papers by Syed A. Ahmed Breakdown of academic impact, for papers by CM Vachon Breakdown of academic impact, for papers by Louise Eriksson Breakdown of academic impact, for papers by Janne Malina Breakdown of academic impact, for papers by José E. Alés‐Martínez Breakdown of academic impact, for papers by Galina Lurie Breakdown of academic impact, for papers by Min Kyoon Kim Breakdown of academic impact, for papers by Sònia Servitja Breakdown of academic impact, for papers by Melanie R. Palomares
Rankless by CCL
2026